Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila.

Dokucu ME, Yu L, Taghert PH.

Neuropsychopharmacology. 2005 Dec;30(12):2216-24.

2.

Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.

Padiath QS, Paranjpe D, Jain S, Sharma VK.

Chronobiol Int. 2004 Jan;21(1):43-55.

PMID:
15129823
3.

Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.

Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, Salinas PC.

Mol Cell Neurosci. 2002 Jun;20(2):257-70.

PMID:
12093158
4.

Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.

Kozikowski AP, Gunosewoyo H, Guo S, Gaisina IN, Walter RL, Ketcherside A, McClung CA, Mesecar AD, Caldarone B.

ChemMedChem. 2011 Sep 5;6(9):1593-602. doi: 10.1002/cmdc.201100188.

5.

Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei.

Iwahana E, Akiyama M, Miyakawa K, Uchida A, Kasahara J, Fukunaga K, Hamada T, Shibata S.

Eur J Neurosci. 2004 Apr;19(8):2281-7.

PMID:
15090054
6.

The Wnt signaling pathway in bipolar disorder.

Gould TD, Manji HK.

Neuroscientist. 2002 Oct;8(5):497-511. Review.

PMID:
12374432
7.

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Chen G, Huang LD, Jiang YM, Manji HK.

J Neurochem. 1999 Mar;72(3):1327-30.

8.

Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus.

Welsh DK, Moore-Ede MC.

Biol Psychiatry. 1990 Jul 15;28(2):117-26.

PMID:
2116188
9.

Cytoprotection by lithium and valproate varies between cell types and cellular stresses.

Lai JS, Zhao C, Warsh JJ, Li PP.

Eur J Pharmacol. 2006 Jun 6;539(1-2):18-26.

PMID:
16678157
10.

Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouse.

Mohawk JA, Miranda-Anaya M, Tataroglu O, Menaker M.

Behav Pharmacol. 2009 Mar;20(2):174-83. doi: 10.1097/FBP.0b013e32832a8f43.

11.

Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients.

McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, Welsh DK.

Transl Psychiatry. 2013 Oct 22;3:e318. doi: 10.1038/tp.2013.90.

12.

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM.

Mol Psychiatry. 2009 Jan;14(1):51-9.

PMID:
17925795
13.

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

Kozikowski AP, Gaisina IN, Yuan H, Petukhov PA, Blond SY, Fedolak A, Caldarone B, McGonigle P.

J Am Chem Soc. 2007 Jul 4;129(26):8328-32.

PMID:
17552518
14.

Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity.

Kozlovsky N, Nadri C, Belmaker RH, Agam G.

Int J Neuropsychopharmacol. 2003 Jun;6(2):117-20.

PMID:
12890304
15.

Antimanic drugs stabilize hamster circadian rhythms.

Klemfuss H, Kripke DF.

Psychiatry Res. 1995 Aug 28;57(3):215-22.

PMID:
7501731
16.

Differential effect of lithium on the circadian oscillator in young and old hamsters.

Iwahana E, Hamada T, Uchida A, Shibata S.

Biochem Biophys Res Commun. 2007 Mar 16;354(3):752-6.

PMID:
17254554
17.

Glycogen synthase kinase-3β haploinsufficiency lengthens the circadian locomotor activity period in mice.

Lavoie J, Hébert M, Beaulieu JM.

Behav Brain Res. 2013 Sep 15;253:262-5. doi: 10.1016/j.bbr.2013.08.001.

PMID:
23919927
18.

A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta.

Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20746-51. doi: 10.1073/pnas.0811410106.

19.

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Gould TD, Manji HK.

Neuropsychopharmacology. 2005 Jul;30(7):1223-37. Review.

20.

Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.

Mann L, Heldman E, Bersudsky Y, Vatner SF, Ishikawa Y, Almog O, Belmaker RH, Agam G.

Bipolar Disord. 2009 Dec;11(8):885-96. doi: 10.1111/j.1399-5618.2009.00762.x.

PMID:
19922557

Supplemental Content

Support Center